Brampton — Loblaw Companies Limited, Canada’s largest grocery and pharmacy retailer, reported an increase in both profit and revenue for the third quarter of 2025, driven by steady growth across its food and drug divisions.
The company, which operates well-known brands such as Loblaws and Shoppers Drug Mart, said its profit attributable to common shareholders for the quarter ended October 4, 2025, was $794 million, or 66 cents per diluted share, compared with $777 million, or 63 cents per diluted share, in the same period last year.
Revenue for the 16-week period rose to $19.40 billion, up from $18.54 billion a year earlier, reflecting continued consumer demand despite inflationary pressures and changing spending patterns.
In its retail performance breakdown, food retail same-store sales increased by 2.0%, while drug retail same-store sales climbed 4.0%, supported by a 5.9% increase in pharmacy and health-care sales and a 1.9% rise in front-store sales.
On an adjusted basis, Loblaw reported earnings of 69 cents per diluted share, up from 62 cents a year earlier, marking another quarter of strong operational results.
The company said it remains focused on balancing competitive pricing and value for consumers with continued investment in health, wellness, and convenience through its network of supermarkets and pharmacies.
Loblaw, headquartered in Brampton, Ontario, continues to expand its private-label offerings and loyalty programs, aiming to sustain growth amid a challenging retail landscape and shifting consumer trends.